TrialJournal of Crohn's & colitis2016

Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis.

Raja Atreya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.